Infirem (Dapoxetine)

Dapoxetine blocks the serotonin transporter, preventing reuptake of serotonin at nerve endings. This raises serotonin levels in the synaptic cleft, which modulates the ejaculatory reflex and extends the time before ejaculation occurs.

The specific dose of Infirem is determined by the prescribing clinician based on individual patient factors and local guidelines. Patients should follow the dosage instructions provided by their healthcare professional.

Safety of dapoxetine in pregnancy or while breastfeeding has not been established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To request Infirem, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Infirem (dapoxetine) is a short‑acting SSRI specifically approved for on‑demand use, whereas other treatments such as topical anesthetics or behavioral therapy have different mechanisms and dosing schedules. Dapoxetine offers a rapid onset and convenient oral administration, but individual response varies.

Infirem tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and keep out of reach of children.

Infirem is taken orally, usually 1–3 hours before anticipated sexual activity. The tablet should be swallowed whole with a glass of water and not chewed or crushed.

Serious risks include serotonin syndrome, severe allergic reactions, syncope, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as high fever, muscle rigidity, rash with swelling, fainting, or irregular heartbeats.

Infirem is contraindicated in patients taking MAO inhibitors, other serotonergic antidepressants, pimozide, or those with uncontrolled hypertension, significant cardiac disease, severe liver impairment, or known hypersensitivity to dapoxetine.